Emmaus Life Sciences Submits New Drug Application for Sickle Cell Disease TreatmentSeptember 08, 2016 Read More
Emmaus Life Sciences Joins New Sickle Cell Disease Coalition, Issues Call To Action To Improve Treatment And CareSeptember 06, 2016 Read More
Emmaus Life Sciences to Seek Marketing Approval for First New Sickle Cell Disease Treatment in Nearly 20 Years; Expects to Submit New Drug Application to FDA in SeptemberAugust 22, 2016 Read More
Emmaus Medical Signs Licensing Agreement with Tokyo-Based Regenerative Medicine Company, CellSeedJune 17, 2016 Read More
